Projects funded by the NCN

A triple agonist of glucagon, GLP-1, and GIP receptors as a novel therapeutic option for the treatment of heart failure ...

Call: SONATA 20 , Panel: NZ5

Principal investigator: dr Marta Katarzyna Oknińska

CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

Self-learning systems in the design of compounds modulating GPCR receptors activation.

Call: OPUS 20 , Panel: NZ2

Principal investigator: dr hab. Dorota Latek

Uniwersytet Warszawski, Wydział Chemii

Dysfunction of pancreatic isles in type 2 diabetes – role of fatty acids and epigenetic mechanisms in maintenance of pan...

Call: PRELUDIUM 14 , Panel: NZ3

Principal investigator: Aneta Maria Dobosz

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Feeding time. Multidimensional studies on the impact of satiety signals on circadian timing system in the development of...

Call: OPUS 13 , Panel: NZ4

Principal investigator: prof. Marian Henryk Lewandowski

Uniwersytet Jagielloński, Wydział Biologii

Pheonixin as novel regulator of pancreatic alfa and beta cell functions

Call: PRELUDIUM 13 , Panel: NZ4

Principal investigator: dr Maria Małgorzata Billert

Uniwersytet Przyrodniczy w Poznaniu, Wydział Medycyny Weterynaryjnej i Nauk o Zwierzętach

The role of the factors involved in the brain glucose metabolism in the model of obesity and depression comorbidity

Call: OPUS 7 , Panel: NZ7

Principal investigator: prof. Bogusława Budziszewska

Instytut Farmakologii PAN

Lipid-signaling in regulation of pancreatic islet development: novel function od stearoyl-CoA desaturase and monoacylgly...

Call: SONATA BIS 3 , Panel: NZ3

Principal investigator: prof. Agnieszka Dobrzyń

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

The influence of glucagon-like peptied-1 receptor agaonists on regulation of coticotropin-releasing hormone gene promote...

Call: PRELUDIUM 4 , Panel: NZ7

Principal investigator: Jan Stanisław Detka

Instytut Farmakologii PAN